Clinical Trial Update: Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a hyperosmolar sodium lactate infusion for resuscitation in hemorrhagic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock

Drugs mentioned

• Hyperosmolar Sodium Lactate Infusion (Sodium lactate infusion (hyperosmolar))

Snippet

Sponsor: Innogene Kalbiotech Pte. Ltd | Conditions: Hemorrhagic Shock | Phase 3 | Status: COMPLETED